Examination of the potential therapeutic effect of 4-ASA on patients with ulcerative colitis. This is an FDA """"""""Orphan Drug"""""""" sponsored double blind randomized 6 week controlled trial that includes state of the art assessment of the severity of the disease.
Showing the most recent 10 out of 94 publications